SCYNEXIS, Inc. (SCYX)
NCM – Real vaqt narxi. Valyuta: USD
0.78
-0.04 (-5.35%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
0.78
-0.04 (-5.35%)
Yopilishda: May 12, 2026, 4:00 PM EDT
SCYNEXIS, Inc., biotexnologiya kompaniyasi, Qo'shma Shtatlarda davolash qiyin bo'lgan va dorilarga chidamli qo'ziqorin infektsiyalarini davolash va oldini olish uchun dori ishlab chiqish bilan shug'ullanadi. Kompaniya vulvovaginal kandidoz bilan og'rigan bemorlarni davolash va takrorlanishlar sonini kamaytirish uchun BREXAFEMME ni taklif etadi. Shuningdek, u invaziv qo'ziqorin infektsiyalarini davolash uchun I fazali klinik sinovda bo'lgan SCY-247 ni ishlab chiqmoqda. Kompaniya ilgari SCYNEXIS Chemistry & Automation, Inc. nomi bilan tanilgan va 2002 yil iyun oyida SCYNEXIS, Inc. nomini o'zgartirgan. SCYNEXIS, Inc. 1999 yilda ro'yxatga olingan va Nyu-Jersi shtatidagi Jersi-Siti shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. David Gonzalez Angulo M.D. | CEO, President & Director |
| Mr. Ivor Macleod C.P.A., M.B.A. | Chief Financial Officer |
| Mr. Scott Sukenick J.D. | Chief Legal Officer & Corporate Secretary |
| Ms. Daniella Gigante | Vice President of Human Resources & Information Technology |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-01 | S-3 | d20395ds3.htm |
| 2026-04-30 | DEF 14A | ny20069793x2_def14a.htm |
| 2026-04-27 | DEF 14A | ny20069828x2_def14a.htm |
| 2026-04-20 | PRE 14A | ny20069793x1_pre14a.htm |
| 2026-04-17 | PRE 14A | ny20069828x1_pre14a.htm |
| 2026-03-31 | 8-K | d122408d8k.htm |
| 2026-03-04 | 10-K | scyx-20251231.htm |
| 2025-11-05 | 10-Q | scyx-20250930.htm |
| 2025-10-15 | 8-K | scyx-20251014.htm |
| 2025-08-13 | 10-Q | scyx-20250630.htm |